NR3C2 and prostate cancer: While the mechanism by which MR inhibits prostate cancer development is not known, evidence suggests that MR may work by inhibiting prostate cancer cell proliferation, inhibiting the insulin/IGF-1 axis, or by reducing polyamine synthesis [82].